Literature DB >> 29908844

Tissue-associated self-antigens containing exosomes: Role in allograft rejection.

Monal Sharma1, Ranjithkumar Ravichandran1, Sandhya Bansal1, Ross M Bremner1, Michael A Smith1, T Mohanakumar2.   

Abstract

Exosomes are extracellular vesicles that express self-antigens (SAgs) and donor human leukocyte antigens. Tissue-specific exosomes can be detected in the circulation following lung, heart, kidney and islet cell transplantations. We collected serum samples from patients who had undergone lung (n = 30), heart (n = 8), or kidney (n = 15) transplantations to isolate circulating exosomes. Exosome purity was analyzed by Western blot, using CD9 exosome-specific markers. Tissue-associated lung SAgs, collagen V (Col-V) and K-alpha 1 tubulin (Kα1T), heart SAgs, myosin and vimentin, and kidney SAgs, fibronectin and collagen IV (Col-IV), were identified using western blot. Lung transplant recipients diagnosed with bronchiolitis obliterans syndrome had exosomes with higher expression of Col-V (4.2-fold) and Kα1T (37.1-fold) than stable. Exosomes isolated from heart transplant recipients diagnosed with coronary artery vasculopathy had a 3.9-fold increase in myosin and a 4.7-fold increase in vimentin compared with stable. Further, Kidney transplant recipients diagnosed with transplant glomerulopathy had circulating exosomes with a 2-fold increased expression of fibronectin and 2.5-fold increase in Col-IV compared with stable. We conclude that circulating exosomes with tissue associated SAgs have the potential to be a noninvasive biomarker for allograft rejection.
Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allograft rejection; Biomarker; Exosomes; Self-antigens; Tissue restricted antigens

Mesh:

Substances:

Year:  2018        PMID: 29908844      PMCID: PMC6098724          DOI: 10.1016/j.humimm.2018.06.005

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  36 in total

1.  Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  A Jaramillo; M A Smith; D Phelan; S Sundaresan; E Trulock; J Lynch; J Cooper; G A Patterson; T Mohanakumar
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

2.  Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.

Authors:  Prashanth Vallabhajosyula; Laxminarayana Korutla; Andreas Habertheuer; Ming Yu; Susan Rostami; Chao-Xing Yuan; Sanjana Reddy; Chengyang Liu; Varun Korutla; Brigitte Koeberlein; Jennifer Trofe-Clark; Michael R Rickels; Ali Naji
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

3.  Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy.

Authors:  N Angaswamy; C Klein; V Tiriveedhi; J Gaut; S Anwar; A Rossi; D Phelan; J R Wellen; S Shenoy; W C Chapman; T Mohanakumar
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

4.  Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection.

Authors:  Muthukumar Gunasekaran; Monal Sharma; Ramsey Hachem; Ross Bremner; Michael A Smith; Thalachallour Mohanakumar
Journal:  J Immunol       Date:  2018-02-28       Impact factor: 5.422

5.  The human exosome and disease.

Authors:  Raymond H J Staals; Ger J M Pruijn
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

6.  De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children.

Authors:  Laura E Hesemann; Vijay Subramanian; Thalachallour Mohanakumar; Vikas R Dharnidharka
Journal:  Pediatr Transplant       Date:  2015-06-09

Review 7.  Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery.

Authors:  Francesca Raimondo; Lavinia Morosi; Clizia Chinello; Fulvio Magni; Marina Pitto
Journal:  Proteomics       Date:  2011-01-17       Impact factor: 3.984

8.  HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

Authors:  S Sundaresan; T Mohanakumar; M A Smith; E P Trulock; J Lynch; D Phelan; J D Cooper; G A Patterson
Journal:  Transplantation       Date:  1998-03-15       Impact factor: 4.939

9.  Donor dendritic cell-derived exosomes promote allograft-targeting immune response.

Authors:  Quan Liu; Darling M Rojas-Canales; Sherrie J Divito; William J Shufesky; Donna Beer Stolz; Geza Erdos; Mara L G Sullivan; Gregory A Gibson; Simon C Watkins; Adriana T Larregina; Adrian E Morelli
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

10.  MicroRNA-155 regulates T cell proliferation through targeting GSK3β in cardiac allograft rejection in a murine transplantation model.

Authors:  Zhiyu Feng; Yu Xia; Mingjie Zhang; Jinghao Zheng
Journal:  Cell Immunol       Date:  2013-04-10       Impact factor: 4.868

View more
  13 in total

Review 1.  Clinical relevance of lung-restricted antibodies in lung transplantation.

Authors:  Mahzad Akbarpour; Qiang Wu; Xianpeng Liu; Haiying Sun; Emilia Lecuona; Rade Tomic; Sangeeta Bhorade; Thalachallour Mohanakumar; Ankit Bharat
Journal:  Hum Immunol       Date:  2019-05-08       Impact factor: 2.850

Review 2.  Autoantibodies in lung transplantation.

Authors:  Angara Sureshbabu; Timothy Fleming; Thalachallour Mohanakumar
Journal:  Transpl Int       Date:  2019-08-27       Impact factor: 3.782

3.  An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants.

Authors:  Zhiyi Liu; Fuyi Liao; Davide Scozzi; Yuka Furuya; Kaitlyn N Pugh; Ramsey Hachem; Delphine L Chen; Marlene Cano; Jonathan M Green; Alexander S Krupnick; Daniel Kreisel; Anne Karina T Perl; Howard J Huang; Steven L Brody; Andrew E Gelman
Journal:  JCI Insight       Date:  2019-04-16

4.  Global Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Lung Transplant Recipients.

Authors:  Sandhya Bansal; Marissa McGilvrey; Krystine Garcia-Mansfield; Ritin Sharma; Ross M Bremner; Michael A Smith; Ramsey Hachem; Patrick Pirrotte; Thalachallour Mohanakumar
Journal:  ACS Omega       Date:  2020-06-12

Review 5.  Novel Aspects of Extracellular Vesicles in the Regulation of Renal Physiological and Pathophysiological Processes.

Authors:  Juan Pablo Rigalli; Eric Raul Barros; Vera Sommers; René J M Bindels; Joost G J Hoenderop
Journal:  Front Cell Dev Biol       Date:  2020-04-15

6.  Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.

Authors:  Monal Sharma; Muthukumar Gunasekaran; Ranjithkumar Ravichandran; Cynthia E Fisher; Ajit P Limaye; Chengcheng Hu; John McDyer; Vaidehi Kaza; Ankit Bharat; Sofya Tokman; Ashraf Omar; Ashwini Arjuna; Rajat Walia; Ross M Bremner; Michael A Smith; Ramsey R Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2020-07-07       Impact factor: 10.247

7.  Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.

Authors:  Yoshihiro Itabashi; Ranjithkumar Ravichandran; Sandhya Bansal; Ankit Bharat; Ramsey Hachem; Ross Bremner; Michael Smith; T Mohanakumar
Journal:  Transplantation       Date:  2021-06-01       Impact factor: 5.385

Review 8.  Clinical applications of exosome membrane proteins.

Authors:  Qian Hu; Hang Su; Juan Li; Christopher Lyon; Wenfu Tang; Meihua Wan; Tony Ye Hu
Journal:  Precis Clin Med       Date:  2020-02-24

Review 9.  Extracellular Vesicles as Mediators of Cellular Crosstalk Between Immune System and Kidney Graft.

Authors:  Marco Quaglia; Sergio Dellepiane; Gabriele Guglielmetti; Guido Merlotti; Giuseppe Castellano; Vincenzo Cantaluppi
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

Review 10.  A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies.

Authors:  Tineke Kardol-Hoefnagel; Henny G Otten
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.